BlackRock Group’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2016
Q4 | $4.1M | Buy |
53,775
+4,230
| +9% | +$322K | ﹤0.01% | 1288 |
|
2016
Q3 | $4.13M | Sell |
49,545
-7,189
| -13% | -$599K | ﹤0.01% | 1197 |
|
2016
Q2 | $4.68M | Sell |
56,734
-2,304
| -4% | -$190K | ﹤0.01% | 1116 |
|
2016
Q1 | $4.48M | Sell |
59,038
-254,902
| -81% | -$19.4M | ﹤0.01% | 1120 |
|
2015
Q4 | $25.2M | Sell |
313,940
-398,739
| -56% | -$32.1M | 0.01% | 730 |
|
2015
Q3 | $45.3M | Buy |
712,679
+5,680
| +0.8% | +$361K | 0.03% | 593 |
|
2015
Q2 | $49.7M | Buy |
706,999
+62,556
| +10% | +$4.4M | 0.03% | 599 |
|
2015
Q1 | $51.1M | Buy |
644,443
+81,496
| +14% | +$6.46M | 0.03% | 586 |
|
2014
Q4 | $35.8M | Buy |
562,947
+67,111
| +14% | +$4.27M | 0.02% | 665 |
|
2014
Q3 | $29.6M | Buy |
495,836
+77,650
| +19% | +$4.64M | 0.02% | 692 |
|
2014
Q2 | $22.4M | Sell |
418,186
-12,939
| -3% | -$692K | 0.01% | 755 |
|
2014
Q1 | $26M | Buy |
431,125
+402,931
| +1,429% | +$24.3M | 0.02% | 705 |
|
2013
Q4 | $1.5M | Sell |
28,194
-311
| -1% | -$16.5K | ﹤0.01% | 1715 |
|
2013
Q3 | $1.32M | Buy |
28,505
+2,158
| +8% | +$99.9K | ﹤0.01% | 1720 |
|
2013
Q2 | $1.08M | Buy |
+26,347
| New | +$1.08M | ﹤0.01% | 1686 |
|